This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vagus Nerve Stimulator Market

Market Insights on Vagus Nerve Stimulator covering sales outlook, demand forecast & up-to-date key trends

Vagus Nerve Stimulator Market By Application (Pain Management, Epileptic Seizures, Obesity Management, Depression And Anxiety) & Region - Forecast 2018-2026

Restoration of Nerve Functionality in Neurological Disorders

Over the years, the burden of neurological diseases is increasing in emerging countries. According to estimates by the WHO, 4.5–11% of illnesses in both low- and high-income economies is triggered due to neurological disorders. The situation is more critical as compared to the patients suffering from respiratory ailments, gastrointestinal disorders, or cancers.

It is expected that the burden is expected to increase further over the forecast period. Neurological failure can also lead to permanent paralysis or disability, which becomes burden not only for the patients but also to their families. To overcome such complex situations, Vagus Nerve Stimulator therapy for last decades has been in use to overcome the improving neurological tremors, and dyskinesia, among others.

This system creates muscle contraction and is able to restore functionality of motor nerve. Besides, vagus nerve stimulators can also be used in patients for bladder control, restoration of hand grasp, and movement. Vagus nerve stimulator can be used for normalizing other neurological disorders such as migraines, Crohn's disease, Asthma, depression, headaches and cardiovascular diseases.

Customize this Report

Let us know your requirement to get
100% FREE customization

Next-generation Technology – Possible Future Therapy for Neurological Disorders

Over the last two decades, treatment and gene delivery using vectors as carrier have been in peak of research to treat various neurological disorders. Also, vector-based gene modification have undergone remarkable changes against rising demand for transgene delivery to the host. For instance, vector development to treat patients with nervous system disorders using gene-induced vectors have undergone massive advancements.

Additionally, other vectors, e.g., lentiviral vector, has also been used widely in CNS gene therapy, as the vector has a larger transgene capacity. Besides, Herpes simplex virus and adenoviral vectors have also been utilized to treat CNS disorders. With advancements in next generation technology, it could possibly replace the shortcomings of implantable vagus nerve stimulators.

Vagus Nerve Stimulator Market Download Report Brochure

Paradigm Shift Towards Minimally Invasive VNS Procedures

Over the past decades, it is been observed that Implantable VNS is associated with surgically related infections and abnormal complexities such as dysrhythmia, cough, paresthesia, pain and voice alteration, which gradually decreases the prevalence over time. To overcome such side effects of implantable vagus nerve stimulator, companies such as Cerbomed and Electrocore in this decade have made commendable progress in their product research to introduce noninvasive vagus nerve stimulators to the world.

The devices were initially introduced in European region. Gradually, with recent FDA approvals and clearance for noninvasive vagus nerve stimulator product marketing and licensing, the devices have made strides and being accepted globally in various neurological treatment.

It is expected that the external vagus nerve stimulator is expected to provide an advanced hygienic and noninfectious profile as it does not requires implantation. Additionally, the external VNS devices are more effective in terms of treatment and are also affordable for patients.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

High Maintenance and Device Costs to Restrain Adoption of Vagus Nerve Stimulators

In a research study, it is reported that 105 patients receiving vagus nerve stimulator system treatment from 1999 to 2008, twenty (19%) patients had encountered device-related technical failures and complications. Amongst device failures, first the device was removed in 8 cases. Others also encountered some of the device-associated complications such as electrode malfunction, onset of wound infections & cardiac arrhythmia and posttraumatic dysfunction of the stimulator.

Vagus nerve stimulator therapy is also associated with wide array of possible complications. Other simultaneous technical failures include malfunction of dislocation, and generator. The major complication occurs in children, and the primary reason being electrode fracture, which might be induced by growth during the adolescence stage.

Once the neurologist prescribes vagus nerve stimulation therapy as one option for treatment of any neurological disorder, there comes this question as how much this treatment costs. The cost of vagus nerve stimulator therapy currently is high, including both the implant and surgical procedure. Costs of surgery and post-surgical care may vary in different parts of the world and may further increase over time.

Many insurance companies, such as Medicare and most Medicaid carriers, in the West cover almost all the costs of the vagus nerve stimulator therapy. However, people qualifying for vagus nerve stimulator therapy but without insurance cover or external funds need to pay the whole amount for the implant, which becomes a long-term burden for the patient.

Competitive Landscape

This section of the report features profiles of key players operating in the vagus nerve stimulator market based on their market shares, differential strategies, vagus nerve stimulator product offerings, marketing approach and company dashboard. Examples of some of the key players featured in this report include ElectroCore LivaNova LLC, Cerbomed GmbH, ReShape Lifesciences, Inc., and NERVANA LLC, among others.

The key manufacturers of vagus nerve stimulator are focusing on marketing strategies to increase both their product portfolio as well as geographical presence. The company’s manufacturing vagus nerve stimulator are focused on pricing strategies in order to lead in the market for vagus nerve stimulator.

Some other key market strategies followed by vagus nerve stimulator manufacturers include lucrative discounts, strong distribution network for consumables and equipment, partnering with local as well as global retailers, and long-term partnerships with pathology laboratories, hospitals and contract research organizations.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Definition

Implantable vagus nerve stimulator is a neuromodulation device, which is surgically implanted inside the skin of the chest, and a wire is inserted under the skin connecting the device to the left vagus nerve. Transcutaneous vagus nerve stimulator (tVNS) or noninvasive vagus nerve stimulation devices do not require any surgical implantation. The devices are handheld and used to treat epilepsy, pain-management and pain.

About the Report

FMI conducted a research study on vagus nerve stimulator marketfor the forecast period 2018 to 2028. The vagus nerve stimulator marketreport offers a comprehensive evaluation of the business opportunities prevailing in the vagus nerve stimulator marketalong with insights on the vagus nerve stimulator, trend, device prices and awareness level for vagus nerve stimulator marketcompetition. The report elaborates the macroeconomic factors influencing the dynamics of vagus nerve stimulator marketand its futuristic potential.

Additional Questions Answered

Some of the additional questions addressed in this report on vagus nerve stimulator market-

  • What the revenue potential of vagus nerve stimulator market acrossNorth America and Europe?
  • Who are the key competitors and what are their portfolios in the vagus nerve stimulator market?
  • What are major challenges influencing the growth of the vagus nerve stimulator market?
  • How intervention from regulatory authority is shaping the vagus nerve stimulator marketgrowth?

Research Methodology

The vagus nerve stimulator markethas been estimated based on supply-demand approach. The market was first calculated based on vagus nerve stimulator volume conducted in different region/countries. The test volume was estimated based on instrument installation in top 20 countries globally. Other qualitative factors analyzed during test volume estimation include awareness level neurological disorders.

This information was further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases).

The research study on vagus nerve stimulator marketalso includes top trends and macro as well as micro-economic factors shaping the vagus nerve stimulator market. With this approach, the report on vagus nerve stimulator marketanticipates the industry attractiveness of every major segment in the vagus nerve stimulator market over the forecast period.

Segmentation

The report offers a comprehensive taxonomy of vagus nerve stimulator marketbased on product type, end user, application type and region. Based on product type, the vagus nerve stimulator market is segmented into implantable and noninvasive (tVNS) based. The vagus nerve stimulator finds application in pain management, epileptic seizures, obesity management, depression and anxiety.

These vagus nerve stimulators are used by hospitals, ambulatory surgical centers, specialty clinics and home care settings. The vagusnerve stimulator markethas been analysed across regions of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan and MEA.

Frequently Asked Questions

The vagus nerve stimulator market is likely to register a CAGR of 9.89% during the forecast period.

The major complication occurs in children during the adolescent stage due to electrode fracture induced by growth.

By 2032, the market is likely to grow to a revenue of US$ 1,647.43 Mn.

North America holds the leading market share of vagus nerve stimulators.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition, by product type

3. Market Dynamics

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

    3.3. Drivers

    3.4. Restraints

    3.5. Trends

    3.6. Forecast Factors and Relevance of impact

4. Key Inclusions

    4.1. Pricing Analysis

    4.2. Technology Assessment

    4.3. Product Life Cycle Analysis

    4.4. Install Base Analysis, By Region

5. Global Market Analysis 2013–2017 and Forecast 2018–2028,

    5.1. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017

        5.1.1. North America

        5.1.2. Latin America

        5.1.3. Europe

        5.1.4. Asia Pacific excluding Japan

        5.1.5. Japan

        5.1.6. Middle East and Africa

    5.2. Market Size (US$ Mn) Forecast By Region, 2018–2028

    5.3. Market Attractiveness Analysis By Region

    5.4. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2013–2017

        5.4.1. Implantable Vagus Nerve Stimulator

        5.4.2. Transcutaneous (tVNS)

    5.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    5.6. Market Attractiveness Analysis By Product Type

    5.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        5.7.1. Hospitals

        5.7.2. Ambulatory Surgical Centers

        5.7.3. Specialty Clinics

        5.7.4. Home Care Settings

    5.8. Market Size (US$ Mn) Forecast By End User, 2018–2028

    5.9. Market Attractiveness Analysis By End User

    5.10. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        5.10.1. Pain Management

        5.10.2. Epileptic Seizures

        5.10.3. Obesity

        5.10.4. Depression & Anxiety

        5.10.5. Obstructive Sleep Apnea

        5.10.6. Tinnitus

        5.10.7. Opoid Withdrawal

    5.11. Market Size (US$ Mn) Forecast By Application, 2018–2028

    5.12. Market Attractiveness Analysis By Application

6. North America Market Analysis 2013–2017 and Forecast 2018–2028

    6.1. Introduction

    6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017

        6.2.1. U.S.

        6.2.2. Canada

    6.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

    6.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013–2017

        6.4.1. Implantable Vagus Nerve Stimulator

        6.4.2. Transcutaneous (tVNS)

    6.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2018–2028

    6.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        6.6.1. Hospitals

        6.6.2. Ambulatory Surgical Centers

        6.6.3. Specialty Clinics

        6.6.4. Home Care Settings

    6.7. Market Size (US$ Mn) Forecast By End User, 2018–2028

    6.8. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        6.8.1. Pain Management

        6.8.2. Epileptic Seizures

        6.8.3. Obesity

        6.8.4. Depression & Anxiety

        6.8.5. Obstructive Sleep Apnea

        6.8.6. Tinnitus

        6.8.7. Opoid Withdrawal

    6.9. Market Size (US$ Mn) Forecast By Application, 2018–2028

    6.10. Market Attractiveness Analysis

        6.10.1. By Country

        6.10.2. By Product Type

        6.10.3. By End User

        6.10.4. By Application

    6.11. Key Market Participants – Intensity Mapping

    6.12. Drivers and Restraints – Impact Analysis

7. Europe Market Analysis 2013–2017 and Forecast 2018–2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) By Country, 2013–2017

        7.2.1. Germany

        7.2.2. France

        7.2.3. U.K.

        7.2.4. Spain

        7.2.5. Italy

        7.2.6. Russia

        7.2.7. Rest of Europe

    7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

    7.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013–2017

        7.4.1. Implantable Vagus Nerve Stimulator

        7.4.2. Transcutaneous (tVNS)

    7.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2018–2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        7.6.1. Hospitals

        7.6.2. Ambulatory Surgical Centers

        7.6.3. Specialty Clinics

        7.6.4. Home Care Settings

    7.7. Market Size (US$ Mn) Forecast By End User, 2018–2028

    7.8. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        7.8.1. Pain Management

        7.8.2. Epileptic Seizures

        7.8.3. Obesity

        7.8.4. Depression & Anxiety

        7.8.5. Obstructive Sleep Apnea

        7.8.6. Tinnitus

        7.8.7. Opoid Withdrawal

    7.9. Market Size (US$ Mn) Forecast By Application, 2018–2028

    7.10. Market Attractiveness Analysis

        7.10.1. By Country

        7.10.2. By Product Type

        7.10.3. By End User

        7.10.4. By Application

    7.11. Key Market Participants – Intensity Mapping

    7.12. Drivers and Restraints – Impact Analysis

8. Latin America Market Analysis 2013–2017 and Forecast 2018–2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) By Country, 2013–2017

        8.2.1. Brazil

        8.2.2. Mexico

        8.2.3. Rest of Latin America

    8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

    8.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013–2017

        8.4.1. Implantable Vagus Nerve Stimulator

        8.4.2. Transcutaneous (tVNS)

    8.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2018–2028

    8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        8.6.1. Hospitals

        8.6.2. Ambulatory Surgical Centers

        8.6.3. Specialty Clinics

        8.6.4. Home Care Settings

    8.7. Market Size (US$ Mn) Forecast By End User, 2018–2028

    8.8. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        8.8.1. Pain Management

        8.8.2. Epileptic Seizures

        8.8.3. Obesity

        8.8.4. Depression & Anxiety

        8.8.5. Obstructive Sleep Apnea

        8.8.6. Tinnitus

        8.8.7. Opoid Withdrawal

    8.9. Market Size (US$ Mn) Forecast By Application, 2018–2028

    8.10. Market Attractiveness Analysis

        8.10.1. By Country

        8.10.2. By Product Type

        8.10.3. By End User

        8.10.4. By Application

    8.11. Key Market Participants – Intensity Mapping

    8.12. Drivers and Restraints – Impact Analysis

9. Asia Pacific excluding Japan (APEJC) Market Analysis 2013–2017 and Forecast 2018–2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) By Country, 2013–2017

        9.2.1. India

        9.2.2. China

        9.2.3. Australia and New Zealand

        9.2.4. ASEAN

        9.2.5. Rest of APEJ

    9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

    9.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013–2017

        9.4.1. Implantable Vagus Nerve Stimulator

        9.4.2. Transcutaneous (tVNS)

    9.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2018–2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        9.6.1. Hospitals

        9.6.2. Ambulatory Surgical Centers

        9.6.3. Specialty Clinics

        9.6.4. Home Care Settings

    9.7. Market Size (US$ Mn) Forecast By End User, 2018–2028

    9.8. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        9.8.1. Pain Management

        9.8.2. Epileptic Seizures

        9.8.3. Obesity

        9.8.4. Depression & Anxiety

        9.8.5. Obstructive Sleep Apnea

        9.8.6. Tinnitus

        9.8.7. Opoid Withdrawal

    9.9. Market Size (US$ Mn) Forecast By Application, 2018–2028

    9.10. Market Attractiveness Analysis

        9.10.1. By Country

        9.10.2. By Product Type

        9.10.3. By End User

        9.10.4. By Application

    9.11. Key Market Participants – Intensity Mapping

    9.12. Drivers and Restraints – Impact Analysis

10. Japan Market Analysis 2013–2017 and Forecast 2018–2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013–2017

        10.2.1. Implantable Vagus Nerve Stimulator

        10.2.2. Transcutaneous (tVNS)

    10.3. Market Size (US$ Mn) & Volume Forecast By Product Type, 2018–2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Specialty Clinics

        10.4.4. Home Care Settings

    10.5. Market Size (US$ Mn) Forecast By End User, 2018–2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        10.6.1. Pain Management

        10.6.2. Epileptic Seizures

        10.6.3. Obesity

        10.6.4. Depression & Anxiety

        10.6.5. Obstructive Sleep Apnea

        10.6.6. Tinnitus

        10.6.7. Opoid Withdrawal

    10.7. Market Size (US$ Mn) Forecast By Application, 2018–2028

    10.8. Market Attractiveness Analysis

        10.8.1. By Country

        10.8.2. By Product Type

        10.8.3. By End User

        10.8.4. By Application

    10.9. Key Market Participants – Intensity Mapping

    10.10. Drivers and Restraints – Impact Analysis

11. MEA Market Analysis 2013–2017 and Forecast 2018–2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) By Country, 2013–2017

        11.2.1. GCC Countries

        11.2.2. South Africa

        11.2.3. Rest of MEA

    11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

    11.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013–2017

        11.4.1. Implantable Vagus Nerve Stimulator

        11.4.2. Transcutaneous (tVNS)

    11.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2018–2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017

        11.6.1. Hospitals

        11.6.2. Ambulatory Surgical Centers

        11.6.3. Specialty Clinics

        11.6.4. Home Care Settings

    11.7. Market Size (US$ Mn) Forecast By End User, 2018–2028

    11.8. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

        11.8.1. Pain Management

        11.8.2. Epileptic Seizures

        11.8.3. Obesity

        11.8.4. Depression & Anxiety

        11.8.5. Obstructive Sleep Apnea

        11.8.6. Tinnitus

        11.8.7. Opoid Withdrawal

    11.9. Market Size (US$ Mn) Forecast By Application, 2018–2028

    11.10. Market Attractiveness Analysis

        11.10.1. By Country

        11.10.2. By Product Type

        11.10.3. By End User

        11.10.4. By Application

    11.11. Key Market Participants – Intensity Mapping

    11.12. Drivers and Restraints – Impact Analysis

12. Forecast Assumptions

13. Competition Analysis

    13.1. Competition Dashboard

    13.2. Company Deep Dive

        13.2.1. ElectroCore

            13.2.1.1. Overview

            13.2.1.2. Product Portfolio

            13.2.1.3. Production Footprint

            13.2.1.4. Sales Footprint

            13.2.1.5. Channel Footprint

            13.2.1.6. Strategy

                13.2.1.6.1. Marketing Strategy

                13.2.1.6.2. Product Strategy

                13.2.1.6.3. Channel Strategy

        13.2.2. LIvaNova LLC.

            13.2.2.1. Overview

            13.2.2.2. Product Portfolio

            13.2.2.3. Production Footprint

            13.2.2.4. Sales Footprint

            13.2.2.5. Channel Footprint

            13.2.2.6. Strategy

                13.2.2.6.1. Marketing Strategy

                13.2.2.6.2. Product Strategy

                13.2.2.6.3. Channel Strategy

        13.2.3. Cerbomed GmbH

            13.2.3.1. Overview

            13.2.3.2. Product Portfolio

            13.2.3.3. Production Footprint

            13.2.3.4. Sales Footprint

            13.2.3.5. Channel Footprint

            13.2.3.6. Strategy

                13.2.3.6.1. Marketing Strategy

                13.2.3.6.2. Product Strategy

                13.2.3.6.3. Channel Strategy

        13.2.4. NERVANA LLC.

            13.2.4.1. Overview

            13.2.4.2. Product Portfolio

            13.2.4.3. Production Footprint

            13.2.4.4. Sales Footprint

            13.2.4.5. Channel Footprint

            13.2.4.6. Strategy

                13.2.4.6.1. Marketing Strategy

                13.2.4.6.2. Product Strategy

                13.2.4.6.3. Channel Strategy

        13.2.5. ReShape Lifesciences, Inc

            13.2.5.1. Overview

            13.2.5.2. Product Portfolio

            13.2.5.3. Production Footprint

            13.2.5.4. Sales Footprint

            13.2.5.5. Channel Footprint

            13.2.5.6. Strategy

                13.2.5.6.1. Marketing Strategy

                13.2.5.6.2. Product Strategy

                13.2.5.6.3. Channel Strategy

        13.2.6. Beijing PINS Medical Co., Ltd.

            13.2.6.1. Overview

            13.2.6.2. Product Portfol/io

            13.2.6.3. Production Footprint

            13.2.6.4. Sales Footprint

            13.2.6.5. Channel Footprint

            13.2.6.6. Strategy

                13.2.6.6.1. Marketing Strategy

                13.2.6.6.2. Product Strategy

                13.2.6.6.3. Channel Strategy

        13.2.7. Parasym Health

            13.2.7.1. Product Portfolio

            13.2.7.2. Production Footprint

            13.2.7.3. Sales Footprint

            13.2.7.4. Channel Footprint

            13.2.7.5. Strategy

                13.2.7.5.1. Marketing Strategy

                13.2.7.5.2. Product Strategy

                13.2.7.5.3. Channel Strategy

        13.2.8. Innovative Health Solutions INC

            13.2.8.1. Overview

            13.2.8.2. Product Portfolio

            13.2.8.3. Production Footprint

            13.2.8.4. Sales Footprint

            13.2.8.5. Channel Footprint

            13.2.8.6. Strategy

                13.2.8.6.1. Marketing Strategy

                13.2.8.6.2. Product Strategy

                13.2.8.6.3. Channel Strategy

14. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Region

Table 02: Global Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 03: Global Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Table 04: North America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country Type

Table 05: North America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 06: North America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Application Type

Table 07: North America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Table 08: Latin America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country Type

Table 09: Latin America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 10: Latin America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Application Type

Table 11: Latin America Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Table 12: Europe Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country Type

Table 13: Europe Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 14: Europe Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Application Type

Table 15: Europe Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Table 16: APEJ Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country Type

Table 17: APEJ Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 18: APEJ Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Application Type

Table 19: APEJ Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Table 20: Japan Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 21: Japan Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Application Type

Table 22: Japan Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Table 23: MEA Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country Type

Table 24: MEA Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

Table 25: MEA Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Application Type

Table 26: MEA Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Market Value Share By Region (2018)

Figure 02: Global Market Share, By Region (2017)

Figure 03: Global Market Share, By Application (2017)

Figure 04: Global Market Share, By End User (2017)

Figure 05: Global Implantable Market , Price Difference (US$) By Region, 2017

Figure 06: Global Implantable Market , Price Difference (US$) By Region, 2028

Figure 07: Global Transcutaneous (tVNS) Market , Price Difference (US$) By Region, 2017

Figure 08: Global Transcutaneous (tVNS) Market , Price Difference (US$) By Region, 2028

Figure 09: Global Market Size (US$ Mn) Analysis, 2013–2017

Figure 10: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 11: Global Market Attractiveness Analysis, By Region

Figure 12: Global Market Value Share Analysis, By Region, 2017 & 2028

Figure 13: Global Market Attractiveness Analysis, By Test Type

Figure 14: Global Market Value Share Analysis, By Test Type, 2017 & 2028

Figure 15: Global Market Attractiveness Analysis, By End User

Figure 16: Global Market Value Share Analysis, By End User, 2017 & 2028

Figure 17: North America Market, Snapshot

Figure 18: North America Market Value Share, by Product Type (2017)

Figure 19: North America Market Value Share, by End User (2017)

Figure 20: North America Market Value Share, by Application (2017)

Figure 21: North America Market Value Share, by Country(2017)

Figure 22: North America Market Size (US$ Mn) Analysis, 2013–201

Figure 23: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 24: North America Market Attractiveness Analysis, By Product Type

Figure 25: North America Market Attractiveness Analysis, By End User

Figure 26: North America Market Attractiveness Analysis, By Application Type

Figure 27: North America Market Attractiveness Analysis, By Country

Figure 28: Latin America Market, Snapshot

Figure 29: Latin America Market Value Share, by Product Type (2017)

Figure 30: Latin America Market Value Share, by End User (2017)

Figure 31: Latin America Market Value Share, by Application (2017)

Figure 32: Latin America Market Value Share, by Country(2017)

Figure 33: Latin America Market Value Share, by Country(2017)

Figure 34: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 35: Latin America Market Attractiveness Analysis, By Product Type

Figure 36: Latin America Market Attractiveness Analysis, By End User

Figure 37: Latin America Market Attractiveness Analysis, By Application Type

Figure 38: Latin America Market Attractiveness Analysis, By Country

Figure 39: Europe Market, Snapshot

Figure 40: Europe Market Value Share, by Product Type (2017)

Figure 41: Europe Market Value Share, by End User (2017)

Figure 42: Europe Market Value Share, by Application (2017)

Figure 43: Europe Market Value Share, by Country(2017)

Figure 44: Europe Market Size (US$ Mn) Analysis, 2013–2017

Figure 45: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 46: Europe Market Attractiveness Analysis, By Product Type

Figure 47: Europe Market Attractiveness Analysis, By End User

Figure 48: Europe Market Attractiveness Analysis, By Application Type

Figure 49: Europe Market Attractiveness Analysis, By Country

Figure 50: APEJ Market, Snapshot

Figure 51: APEJ Market Value Share, by Product Type (2017)

Figure 52: APEJ Market Value Share, by End User (2017)

Figure 53: APEJ Market Value Share, by Application (2017)

Figure 54: APEJ Market Value Share, by Country(2017)

Figure 55: APEJ Market Size (US$ Mn) Analysis, 2013–2017

Figure 56: APEJ Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 57: APEJ Market Attractiveness Analysis, By Product Type

Figure 58: APEJ Market Attractiveness Analysis, By End User

Figure 59: APEJ Market Attractiveness Analysis, By Application Type

Figure 60: APEJ Market Attractiveness Analysis, By Country

Figure 61: Japan Market, Snapshot

Figure 62: Japan Market Value Share, by Product Type (2017)

Figure 63: Japan Market Value Share, by Product Type (2017)

Figure 64: Japan Market Value Share, by Application (2017)

Figure 65: Japan Market Size (US$ Mn) Analysis, 2013–2017

Figure 66: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 67: Japan Market Attractiveness Analysis, By Product Type

Figure 68: Japan Market Attractiveness Analysis, By End User

Figure 69: Japan Market Attractiveness Analysis, By Application Type

Figure 70: MEA Market, Snapshot

Figure 71: MEA Market Value Share, by Product Type (2017)

Figure 72: MEA Market Value Share, by End User (2017)

Figure 73: MEA Market Value Share, by Application (2017)

Figure 74: MEA Market Value Share, by Country(2017)

Figure 75: MEA Market Size (US$ Mn) Analysis, 2013–2017

Figure 76: MEA Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2028

Figure 77: MEA Market Attractiveness Analysis, By Product Type

Figure 78: Japan Market Value Share, by End User (2017)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Vagus Nerve Stimulator Market